It is noteworthy that putative cancer stem cells expressing the combined CD44+/CD24−/low/ALDH1+ phenotype showed an especially high tumourigenic capacity, being able to form tumours from as few as 20 cells (Ginestier et al, 2007). The gene discussed is CD44; the disease is neoplasm.